Literature DB >> 32393875

Coronavirus blood-clot mystery intensifies.

Cassandra Willyard.   

Abstract

Entities:  

Keywords:  Immunology; Medical research; SARS-CoV-2

Mesh:

Substances:

Year:  2020        PMID: 32393875     DOI: 10.1038/d41586-020-01403-8

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.

Authors:  Julien Poissy; Julien Goutay; Morgan Caplan; Erika Parmentier; Thibault Duburcq; Fanny Lassalle; Emmanuelle Jeanpierre; Antoine Rauch; Julien Labreuche; Sophie Susen
Journal:  Circulation       Date:  2020-04-24       Impact factor: 29.690

2.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

3.  Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.

Authors:  Anuradha Lala; Kipp W Johnson; James L Januzzi; Adam J Russak; Ishan Paranjpe; Felix Richter; Shan Zhao; Sulaiman Somani; Tielman Van Vleck; Akhil Vaid; Fayzan Chaudhry; Jessica K De Freitas; Zahi A Fayad; Sean P Pinney; Matthew Levin; Alexander Charney; Emilia Bagiella; Jagat Narula; Benjamin S Glicksberg; Girish Nadkarni; Donna M Mancini; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2020-06-08       Impact factor: 24.094

4.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

5.  More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.

Authors:  Jamie M O'Sullivan; Soracha Ward; Helen Fogarty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-06-01       Impact factor: 8.615

6.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

7.  D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.

Authors:  Litao Zhang; Xinsheng Yan; Qingkun Fan; Haiyan Liu; Xintian Liu; Zejin Liu; Zhenlu Zhang
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036

  7 in total
  26 in total

Review 1.  Air pollution by NO2 and PM2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in respiratory cells: a review.

Authors:  Biswaranjan Paital; Pawan Kumar Agrawal
Journal:  Environ Chem Lett       Date:  2020-09-18       Impact factor: 9.027

Review 2.  COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar; Brandon M Henry
Journal:  Ann Transl Med       Date:  2020-06

3.  VEGF-D: a novel biomarker for detection of COVID-19 progression.

Authors:  Yaxian Kong; Junyan Han; Xueying Wu; Hui Zeng; Jingyuan Liu; Henghui Zhang
Journal:  Crit Care       Date:  2020-06-23       Impact factor: 9.097

Review 4.  Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.

Authors:  Günther Schönrich; Martin J Raftery; Yvonne Samstag
Journal:  Adv Biol Regul       Date:  2020-07-04

5.  Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report.

Authors:  Etheresia Pretorius; Chantelle Venter; Gert Jacobus Laubscher; Petrus Johannes Lourens; Janami Steenkamp; Douglas B Kell
Journal:  Cardiovasc Diabetol       Date:  2020-11-17       Impact factor: 9.951

6.  COVID-19: Nanomedicine Uncovers Blood-Clot Mystery.

Authors:  Amir Ata Saei; Shahriar Sharifi; Morteza Mahmoudi
Journal:  J Proteome Res       Date:  2020-08-31       Impact factor: 4.466

7.  Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19.

Authors:  Chantelle Venter; Johannes Andries Bezuidenhout; Gert Jacobus Laubscher; Petrus Johannes Lourens; Janami Steenkamp; Douglas B Kell; Etheresia Pretorius
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

Review 8.  COVID-19: The Immune Responses and Clinical Therapy Candidates.

Authors:  Sareh Zhand; Marie Saghaeian Jazi; Saeed Mohammadi; Roozbeh Tarighati Rasekhi; Ghassem Rostamian; Mohammad Reza Kalani; Aida Rostamian; Jacob George; Mark W Douglas
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

Review 9.  Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.

Authors:  Eileen M McGowan; Nahal Haddadi; Najah T Nassif; Yiguang Lin
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

10.  Occurrence of pulmonary embolism related to COVID-19.

Authors:  Marie Hauguel-Moreau; Mostafa El Hajjam; Quentin De Baynast; Antoine Vieillard-Baron; Anne-Sophie Lot; Thierry Chinet; Hazrije Mustafic; Céline Bégué; Robert Yves Carlier; Guillaume Geri; Olivier Dubourg; Sébastien Beaune; Nicolas Mansencal
Journal:  J Thromb Thrombolysis       Date:  2020-10-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.